FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2945338097> ?p ?o ?g. }

• W2945338097 endingPage "174" @default.
• W2945338097 startingPage "165" @default.
• W2945338097 abstract "Emerging immunotherapeutic approaches have revolutionized the treatment of multiple malignancies. Immune checkpoint blockers (ICBs) have enabled never-before-seen success rates in durable tumor control and enhanced survival benefit in patients with advanced cancers. However, this effect is not universal, resulting in responder and nonresponder populations not only between, but also within solid tumor types. Although ICBs are thought to be most effective against tumors with more genetic mutations and higher antigen loads, this is not always the case for all cancers or for all patients within a cancer subtype. Furthermore, debilitating and sometimes deadly immune-related adverse events (irAEs) have resulted from aberrant activation of T-cell responses following immunotherapy. Thus, we must identify new ways to overcome resistance to ICB-based immunotherapies and limit irAEs. In fact, preclinical and clinical data have identified abnormalities in the tumor microenvironment (TME) that can thwart the efficacy of immunotherapies such as ICBs. Here, we will discuss how reprogramming various facets of the TME (blood vessels, myeloid cells, and regulatory T cells [Tregs]) may overcome TME-instigated resistance mechanisms to immunotherapy. We will discuss clinical applications of this strategic approach, including the recent successful phase III trial combining bevacizumab with atezolizumab and chemotherapy for metastatic nonsquamous non–small cell lung cancer that led to rapid approval by the U.S. Food and Drug Administration of this regimen for first-line treatment. Given the accelerated testing and approval of ICBs combined with various targeted therapies in larger numbers of patients with cancer, we will discuss how these concepts and approaches can be incorporated into clinical practice to improve immunotherapy outcomes." @default.
• W2945338097 created "2019-05-29" @default.
• W2945338097 creator A5015585176 @default.
• W2945338097 creator A5015735736 @default.
• W2945338097 creator A5019984630 @default.
• W2945338097 creator A5025353193 @default.
• W2945338097 creator A5084967339 @default.
• W2945338097 date "2019-05-01" @default.
• W2945338097 modified "2023-10-10" @default.
• W2945338097 title "Reprogramming the Tumor Microenvironment to Improve Immunotherapy: Emerging Strategies and Combination Therapies" @default.
• W2945338097 cites W150726349 @default.
• W2945338097 cites W1833987578 @default.
• W2945338097 cites W1973647796 @default.
• W2945338097 cites W1982180094 @default.
• W2945338097 cites W1987802826 @default.
• W2945338097 cites W1992662011 @default.
• W2945338097 cites W2022540958 @default.
• W2945338097 cites W2025381786 @default.
• W2945338097 cites W2026878412 @default.
• W2945338097 cites W2131783235 @default.
• W2945338097 cites W2137816700 @default.
• W2945338097 cites W2142263069 @default.
• W2945338097 cites W2152193889 @default.
• W2945338097 cites W2171481006 @default.
• W2945338097 cites W2179115666 @default.
• W2945338097 cites W2191493147 @default.
• W2945338097 cites W2206643120 @default.
• W2945338097 cites W2294927533 @default.
• W2945338097 cites W2328171087 @default.
• W2945338097 cites W2401985889 @default.
• W2945338097 cites W2415557067 @default.
• W2945338097 cites W2511951051 @default.
• W2945338097 cites W2514202874 @default.
• W2945338097 cites W2565119421 @default.
• W2945338097 cites W2611670894 @default.
• W2945338097 cites W2619691134 @default.
• W2945338097 cites W2623209858 @default.
• W2945338097 cites W2738678436 @default.
• W2945338097 cites W2764256970 @default.
• W2945338097 cites W2785838318 @default.
• W2945338097 cites W2791328450 @default.
• W2945338097 cites W2792220974 @default.
• W2945338097 cites W2792761484 @default.
• W2945338097 cites W2793346580 @default.
• W2945338097 cites W2793411374 @default.
• W2945338097 cites W2805354595 @default.
• W2945338097 cites W2896129123 @default.
• W2945338097 cites W2900813143 @default.
• W2945338097 cites W2909679049 @default.
• W2945338097 cites W2909932177 @default.
• W2945338097 cites W2911526204 @default.
• W2945338097 cites W2911812451 @default.
• W2945338097 cites W2913745075 @default.
• W2945338097 cites W2914098003 @default.
• W2945338097 doi "https://doi.org/10.1200/edbk_237987" @default.
• W2945338097 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6596289" @default.
• W2945338097 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31099649" @default.
• W2945338097 hasPublicationYear "2019" @default.
• W2945338097 type Work @default.
• W2945338097 sameAs 2945338097 @default.
• W2945338097 citedByCount "112" @default.
• W2945338097 countsByYear W29453380972019 @default.
• W2945338097 countsByYear W29453380972020 @default.
• W2945338097 countsByYear W29453380972021 @default.
• W2945338097 countsByYear W29453380972022 @default.
• W2945338097 countsByYear W29453380972023 @default.
• W2945338097 crossrefType "journal-article" @default.
• W2945338097 hasAuthorship W2945338097A5015585176 @default.
• W2945338097 hasAuthorship W2945338097A5015735736 @default.
• W2945338097 hasAuthorship W2945338097A5019984630 @default.
• W2945338097 hasAuthorship W2945338097A5025353193 @default.
• W2945338097 hasAuthorship W2945338097A5084967339 @default.
• W2945338097 hasBestOaLocation W29453380972 @default.
• W2945338097 hasConcept C121608353 @default.
• W2945338097 hasConcept C126322002 @default.
• W2945338097 hasConcept C143998085 @default.
• W2945338097 hasConcept C1491633281 @default.
• W2945338097 hasConcept C203014093 @default.
• W2945338097 hasConcept C2775949291 @default.
• W2945338097 hasConcept C2776107976 @default.
• W2945338097 hasConcept C2776694085 @default.
• W2945338097 hasConcept C2777701055 @default.
• W2945338097 hasConcept C2777802072 @default.
• W2945338097 hasConcept C2780030458 @default.
• W2945338097 hasConcept C2780674031 @default.
• W2945338097 hasConcept C502942594 @default.
• W2945338097 hasConcept C54355233 @default.
• W2945338097 hasConcept C71924100 @default.
• W2945338097 hasConcept C77255625 @default.
• W2945338097 hasConcept C86803240 @default.
• W2945338097 hasConcept C8891405 @default.
• W2945338097 hasConceptScore W2945338097C121608353 @default.
• W2945338097 hasConceptScore W2945338097C126322002 @default.
• W2945338097 hasConceptScore W2945338097C143998085 @default.
• W2945338097 hasConceptScore W2945338097C1491633281 @default.
• W2945338097 hasConceptScore W2945338097C203014093 @default.
• W2945338097 hasConceptScore W2945338097C2775949291 @default.
• W2945338097 hasConceptScore W2945338097C2776107976 @default.

• next